Publications

Determinants of Staphylococcus aureus carriage in the developing infant nasal microbiome.

Author(s): Accorsi EK, Franzosa EA, Hsu T, Joice Cordy R, Maayan-Metzger A, Jaber H, Reiss-Mandel A, Kline M, DuLong C, Lipsitch M, Regev-Yochay G, Huttenhower C|Journal: Genome Biol|PMID: 33308267| December 2020

Staphylococcus aureus is a leading cause of healthcare- and community-associated infections and can be difficult to treat due to antimicrobial…

Characteristics of Clinically Asymptomatic Patients with SARS-CoV-2 Infections, Case Series.

Author(s): Goldenfeld M, Nir-Paz R, Segal G, Bar-On E, Mendelson E, Mandelboim M, Wolf DG, Marom EM, Israely T, Achdout H, Rahav G, Hanage WP, Regev-Yochay G|Journal: Prehosp Disaster Med|PMID: 33198831| November 2020

Up until now, there is much debate about the role of asymptomatic patients and pauci-symptomatic patients in severe acute respiratory…

Genomic epidemiology of meticillin-resistant Staphylococcus aureus ST22 widespread in communities of the Gaza Strip, 2009.

Author(s): Chang Q, Abuelaish I, Biber A, Jaber H, Callendrello A, Andam CP, Regev-Yochay G, Hanage WP, On Behalf Of The Picr Study Group|Journal: Euro Surveill|PMID: 30153881| August 2018

BackgroundRemarkably high carriage prevalence of a community-associated meticillin-resistant (MRSA) strain of sequence type (ST) 22 in the Gaza strip was…

Antibiotics in agriculture and the risk to human health: how worried should we be?

Author(s): Chang Q, Wang W, Regev-Yochay G, Lipsitch M, Hanage WP|Journal: Evol Appl|PMID: 25861382| March 2015

The use of antibiotics in agriculture is routinely described as a major contributor to the clinical problem of resistant disease…

Is methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S. aureus?

Author(s): Mostofsky E, Lipsitch M, Regev-Yochay G|Journal: J Antimicrob Chemother|PMID: 21737459| October 2011

Despite extensive research on the emergence of and treatments for methicillin-resistant Staphylococcus aureus (MRSA), prior studies have not rigorously evaluated…

Re-emergence of the type 1 pilus among Streptococcus pneumoniae isolates in Massachusetts, USA.

Author(s): Regev-Yochay G, Hanage WP, Trzciński K, Rifas-Shiman SL, Lee G, Bessolo A, Huang SS, Pelton SI, McAdam AJ, Finkelstein JA, Lipsitch M, Malley R|Journal: Vaccine|PMID: 20434550| July 2010

Pneumococcal type 1 pilus proteins have been proposed as potential vaccine candidates. Following conjugate pneumococcal vaccination, the prevalence of the…